| TITLE |
DATE |
| Rosetta Genomics Announces New York State Approval for miRview mets^2 |
9-Dec-2011 |
| Study Showing Potential for microRNAs as Biomarkers for Heart Failure
Prognosis Published in European Journal of Heart Failure |
28-Nov-2011 |
| Study Published in World Journal of Gastroenterology Shows Potential for microRNAs to Predict Gastric Cancer Recurrence |
4-Nov-2011 |
| Rosetta Genomics Initiates Closing of Private Placement |
19-Oct-2011 |
| Rosetta Genomics to Raise $1.9 Million in Private Placement |
13-Oct-2011 |
| Rosetta Genomics Restructures to Reduce Operating Expenses and Focus on Commercial Opportunities |
11-Oct-2011 |
| Rosetta Genomics Announces Exclusive License with Avatao Biotech for Distribution of miRview Tests in China |
11-Oct-2011 |
| Rosetta Genomics to Present at Rodman & Renshaw 13th Annual Global Investment Conference |
8-Sep-2011 |
| Rosetta Genomics Reports Preliminary Data on Discovery of Blood-Based microRNA Signature for Identification and Stratification of Heart Failure Patients |
26-Jul-2011 |
| Rosetta Genomics Regains Compliance With NASDAQ Minimum Bid Price Rule |
21-Jul-2011 |
| Rosetta Genomics Launches miRview(R) Lung Test |
14-Jul-2011 |
| Rosetta Genomics Announces One-For-Four Reverse Stock Split |
6-Jul-2011 |
| Rosetta Genomics and UC Davis Researchers to Develop and Validate microRNA Biomarker to Predict Response to Neoadjuvant Chemotherapy in Bladder Cancer |
28-Jun-2011 |
| Data Demonstrating the Ability of miRview mets(2) to Identify Tissue
of Origin in Cancer of Unknown Primary Presented at ASCO 2011 |
16-Jun-2011 |
| Rosetta Genomics Signs Marketing Agreement With PACE Claims Services
for miRview(R) meso |
14-Jun-2011 |
| Rosetta Genomics Reports First Quarter 2011 Financial Results |
1-Jun-2011 |
| Rosetta Genomics and Collaborators to Present Data at ASCO 2011 |
23-May-2011 |
| Rosetta Genomics Announces Issuance of Additional U.S. Patent |
9-May-2011 |
| Rosetta Genomics Launches Oncology Sales Team |
3-May-2011 |
| M. D. Anderson Researchers Demonstrate Power of miRview(TM) mets to
Identify Tissue of Origin in Carcinoma of Unknown Primary |
2-May-2011 |
| Rosetta Genomics Names Brian Markison Board Chairman |
12-Apr-2011 |
| Rosetta Genomics Reports 2010 Fourth Quarter and Full Year Financial
Results |
4-Apr-2011 |
| Rosetta Genomics Announces Changes to Board of Directors |
31-Mar-2011 |
| Rosetta Genomics Announces Continued Listing on NASDAQ |
8-Mar-2011 |
| Rosetta Genomics Announces IPO of Majority-Owned Subsidiary Rosetta
Green in Israel |
22-Feb-2011 |
| Rosetta Genomics to Raise $6.0 Million in Concurrent Private
Placement and Registered Direct Offerings |
17-Feb-2011 |
| Rosetta Genomics Receives NASDAQ Extensions |
8-Feb-2011 |
| Heidelberg University Researchers Demonstrate Power of miRview(TM)
mets to Classify Brain and Spine Metastases |
3-Feb-2011 |
| Rosetta Genomics Advances Development of Its Body Fluids-Based
Diagnostic Tests With Two New Collaborations |
1-Feb-2011 |
| Rosetta Genomics Receives Grant and Joins Rimonim Pharmaceutical
Consortium |
10-Jan-2011 |
| Rosetta Genomics Receives New York State Clinical Laboratory Permit
for Its First Generation microRNA Diagnostic Tests |
3-Jan-2011 |
| Brian Markison to Join Rosetta Genomics Board of Directors |
20-Dec-2010 |
| Rosetta Genomics Announces the Availability of miRview® mets2, a Second Generation Version of miRview® mets |
13-Dec-2010 |
| Rosetta Genomics Announces $2.5 Million Private Placement |
30-Nov-2010 |
| Rosetta Genomics Reports Third Quarter 2010 Financial Results |
30-Nov-2010 |
| Rosetta Genomics Settles Arbitration With Prometheus Laboratories,
Regains U.S. Rights to microRNA-Based Cancer Diagnostic Tests |
23-Nov-2010 |
| Rosetta Genomics Researchers and Collaborators Identify Potential
MicroRNA Drug Target for Hepatocellular Carcinoma |
6-Oct-2010 |
| Rosetta Genomics Restructuring to Reduce Annual Operating Expenses by
$4 Million |
5-Oct-2010 |
| Rosetta Genomics Announces Poster Presentations at the AACR's
Molecular Diagnostics in Cancer Therapeutics Development Conference |
30-Sep-2010 |
| New Data Published in "The Journal of Molecular Diagnostics" Demonstrate Rosetta Genomics' miRview meso is a Highly Sensitive Test for Differentiating Mesothelioma From Carcinomas in the Lung or Pleura |
27-Sep-2010 |
| Heidelberg University Researchers Present Data on miRview mets Assay
at Neuroweek Conference |
23-Sep-2010 |
| Rosetta Genomics Reports Second Quarter 2010 Financial Results |
7-Sep-2010 |
| Rosetta Genomics to Present at the Rodman & Renshaw 12th
Annual Global Investment Conference |
7-Sep-2010 |
| Rosetta Genomics to Host Second Quarter 2010 Conference Call on
Wednesday, September 8, 2010 |
2-Sep-2010 |
| Rosetta Genomics to Present at Leerink Swan's Life Science Tools and
Diagnostics Roundtable Conference |
30-Jul-2010 |
| Rosetta Genomics Names Genekor S.A Exclusive Distributor for Three
microRNA-based Assays in Greece |
29-Jul-2010 |
| Webcast Alert: Rosetta Genomics (ROSG) Announces the LHA Life Sciences & Med Tech Day 2010 Presentation |
15-Jul-2010 |
| Rosetta Genomics and Collaborators Demonstrate MicroRNAs Accurately
Sub-Classify Renal Tumors |
6-Jul-2010 |
| Reimbursement for Rosetta Genomics' miRview(TM) mets Test Now Available
in Israel Through World's Second Largest HMO |
28-Jun-2010 |
| Data Presented at ASCO 2010 by M. D. Anderson Researchers Demonstrate
the ability of miRview(TM) mets to Identify the Most Likely Origin of
Metastases in Cancer of Unknown Primary |
7-Jun-2010 |
| Rosetta Genomics Establishes "Rosetta Green" as Majority-owned
Subsidiary |
3-Jun-2010 |
| CORRECTING and REPLACINGRosetta Genomics and Collaborators to
Present New Data at ASCO 2010 on Clinical Studies Involving miRview mets |
28-May-2010 |
| Rosetta Genomics Reports First Quarter 2010 Financial Results |
26-May-2010 |
| Rosetta Genomics and Collaborators to Present New Data at ASCO 2010
on Clinical Studies Involving miRview mets |
26-May-2010 |
| Joint Study by Rosetta Genomics and NYU Langone Medical Center
Identifies Potential microRNA Drug Target for Mesothelioma |
24-May-2010 |
| Rosetta Genomics To Host First Quarter 2010 Conference Call on
Thursday, May 27, 2010 |
20-May-2010 |
| Rosetta Genomics Identifies 49 Novel microRNAs with Potential to
Provide Novel Molecular Biomarkers and Drug Target Candidates |
18-May-2010 |
| Rosetta Genomics to Present at the 6th
Annual Rodman and Renshaw Global Healthcare Conference |
11-May-2010 |
| Rosetta Genomics Announces New Patent Allowance and Provides
Intellectual Property Update |
10-May-2010 |
| Rosetta Genomics Announces Publication of Study on MicroRNA
Expression for Lung Tumor Classification |
29-Apr-2010 |
| Recent Study Demonstrating the Ability of miRview(TM) squamous to
Reliably Classify Non Small Cell Lung Cancer, to Be Presented at the 2nd
European Lung Conference in Geneva, Switzerland |
22-Apr-2010 |
| Rosetta Genomics to Present Multiple Posters at the American
Association of Cancer Research's (AACR) 101st
Annual Meeting |
12-Apr-2010 |
| Rosetta Genomics Now Processing Fine-Needle Aspirate Cell Block
Samples for Lung Cancer Subclassification |
5-Apr-2010 |
| Rosetta Genomics Reports Fourth Quarter and Full Year 2009 Financial
Results |
31-Mar-2010 |
| Rosetta Genomics Announces Publication of the Development and
Validation Process of miRview(TM) mets in Modern Pathology |
29-Mar-2010 |
| Rosetta Genomics Receives Accreditation from the College of American
Pathologists (CAP) |
25-Mar-2010 |
| Rosetta Genomics to Present at the 22nd Annual Roth OC Growth Stock
Conference |
9-Mar-2010 |
| Joint Study by Rosetta Genomics and NYU Langone Medical Center
Identifies Single microRNA Biomarker for Prognosis of Mesothelioma
Patients |
17-Feb-2010 |
| Rosetta Genomics Announces Issuance of Three U.S. Patents |
3-Feb-2010 |
| Rosetta Genomics Fortifies Patent Position with U.S. Allowance of
Claims Covering Human microRNAs miR-21 and hcmv-miR-UL112 |
29-Jan-2010 |
| Rosetta Genomics Ltd. Closes $5.1 Million Financing; Will Support
Ongoing Development of microRNA-based Diagnostic Pipeline |
19-Jan-2010 |
| Rosetta Genomics Ltd. to Raise $5.1 Million in Registered Direct
Offering |
13-Jan-2010 |
| Rosetta Announces that Johns Hopkins University Researchers
Demonstrate miRview(TM) squamous Classifies Non-Small Cell Lung Cancer with
Extremely High Degree of Accuracy |
13-Jan-2010 |
| Rosetta Genomics Stockholders Elect Two New Directors at Annual
Meeting |
22-Dec-2009 |
| Rosetta Genomics Reports Third Quarter Financial Results, Provides
Business Update |
18-Dec-2009 |
| Rosetta Genomics to Hold Business Update, Pipeline Progress and Third
Quarter Conference Call on December 18 |
9-Dec-2009 |
| Rosetta Genomics Strengthens MicroRNA Intellectual Property Position with Receipt of Additional Patent |
5-Nov-2009 |
| Rosetta Genomics Names Kenneth A. Berlin President and Chief Executive Officer |
3-Nov-2009 |
| Rosetta Genomics to Present at Scientific Conference; Provides Update on Colon Cancer Diagnostic Program |
30-Oct-2009 |
| Rosetta Genomics Names Genetic Technologies Limited Exclusive Distributor for Rosetta's microRNA-based Assays in Australia, New Zealand and Singapore |
22-Oct-2009 |
| Rosetta Genomics to Present at the 2009 Maxim Group Growth Conference |
29-Sep-2009 |
| Rosetta Genomics Reports Second Quarter Financial Results, Provides Business Update |
8-Sep-2009 |
| AXA Diagnostics Named Exclusive Distributor for Rosetta Genomics' microRNA-based Assays in Italy |
8-Sep-2009 |
| Rosetta Genomics to Present at the Rodman & Renshaw 11th Annual Healthcare Conference |
2-Sep-2009 |
| Rosetta Genomics to Hold Second Quarter Conference Call on September 8 |
2-Sep-2009 |
| Rosetta Genomics and Super Religare Laboratories Limited (SRL) Announce Exclusive Distribution Agreement for Rosetta's MicroRNA-based Assays in India, Saudi Arabia, Qatar, and the United Arab Emirates (UAE) |
19-Aug-2009 |
| Rosetta Genomics and Warnex Medical Laboratories Announce Exclusive Distribution Agreement for Rosetta's microRNA-based Assays in Canada |
10-Aug-2009 |
| Rosetta Genomics Passes California, Rhode Island, and Maryland CLIA Certification; Files 2008 Audited Financial Statements on Form 6-K |
17-Jun-2009 |
| Rosetta Genomics To Present At The Eighth Annual Needham and Company Biotechnology and Medical Technology Conference |
8-Jun-2009 |
| Rosetta Genomics Reports First Quarter Financial Results, Announces Sale of Parkway Clinical Laboratories |
21-May-2009 |
| Rosetta Genomics Announces Upcoming Scientific Presentations, Posters, and New Publication |
20-May-2009 |
| Rosetta Genomics to Hold First Quarter Conference Call on May 21 |
12-May-2009 |
| Rosetta Genomics Announces Closing of License and Collaboration Agreement |
30-Apr-2009 |
| Rosetta Genomics to Give Oral Presentation on Colon Cancer Screening Diagnostic at AACR Annual Meeting |
20-Apr-2009 |
| Prometheus and Rosetta Genomics Announce License and Collaboration Agreement |
13-Apr-2009 |
| Rosetta Genomics Reports Fourth Quarter Financial Results, Outlines 2009 Plan Focused on a Noninvasive Colon Cancer Screening Diagnostic |
26-Mar-2009 |
| Study Published by Rosetta Genomics and Collaborators in the Journal of Clinical Oncology Shows MicroRNA-based Diagnostic Identifies Squamous Lung Cancer with 96% Sensitivity |
9-Mar-2009 |
| Rosetta Genomics to Hold Fourth Quarter Conference Call on March 26 |
4-Mar-2009 |
| Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer |
12-Feb-2009 |
| Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum |
16-Jan-2009 |
| Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd. |
8-Jan-2009 |
| Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso |
29-Dec-2008 |
| Rosetta Genomics Announces Commercial Availability of its Second MicroRNA-Based Diagnostic Test - miRview(TM) mets; Will Hold Teleconference Today to Discuss Launch of Products |
22-Dec-2008 |
| Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests |
11-Dec-2008 |
| Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2008 Healthcare Conference |
5-Dec-2008 |
| Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS |
5-Dec-2008 |
| Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results |
26-Nov-2008 |
| Rosetta Genomics to Present at Rodman & Renshaw 10th Annual Healthcare Conference |
5-Nov-2008 |
| Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference |
3-Nov-2008 |
| Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference |
29-Oct-2008 |
| Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics |
27-Oct-2008 |
| Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative |
27-Oct-2008 |
| Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer" |
23-Oct-2008 |
| Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay |
2-Oct-2008 |
| Rosetta Genomics is the Winner of the Medical-Biotech Category in This Year's Wall Street Journal Technology Innovation Awards |
29-Sep-2008 |
| Rosetta Genomics to Present at Maxim Group Growth Conference |
24-Sep-2008 |
| Rosetta Genomics Announces Transfer of MicroRNA-based Liver Therapeutics Project With Isis Pharmaceuticals, Inc. to Regulus Therapeutics LLC |
23-Sep-2008 |
| MicroRNA First Disclosed by Rosetta Genomics may Increase Efficacy of Imatinib (Gleevec(R)(1)) in Glioblastoma |
18-Sep-2008 |
| Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum |
5-Sep-2008 |
| Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV |
20-Aug-2008 |
| Rosetta Genomics Reports Second Quarter 2008 Financial Results |
19-Aug-2008 |
| Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results |
12-Aug-2008 |
| M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases |
11-Aug-2008 |
| Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc. |
24-Jul-2008 |
| First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval |
22-Jul-2008 |
| Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain |
9-Jul-2008 |
| Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference |
3-Jul-2008 |
| Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer |
25-Jun-2008 |
| Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics |
25-Jun-2008 |
| Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development |
18-Jun-2008 |
| Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests |
11-Jun-2008 |
| Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer |
6-Jun-2008 |
| Rosetta Genomics Reports First Quarter 2008 Financial Results |
21-May-2008 |
| Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
16-May-2008 |
| Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results |
14-May-2008 |
| Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate |
28-Apr-2008 |
| Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology |
14-Apr-2008 |
| Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference |
11-Apr-2008 |
| Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica |
3-Apr-2008 |
| Accurate Identification of Tumor Origin Using MicroRNAs is Published by Rosetta Genomics' Scientists and Collaborators in Nature Biotechnology |
24-Mar-2008 |
| Rosetta Genomics Announces Allowance of Two Additional microRNA Patents |
3-Mar-2008 |
| Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results |
29-Feb-2008 |
| Rosetta Genomics Announces Conference Call and Webcast of Fourth Quarter Financial Results |
21-Feb-2008 |
| Rosetta Genomics Establishes Medical Advisory Board |
4-Feb-2008 |
| Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer |
14-Jan-2008 |
| Rosetta Genomics Licenses Roche PCR Technology for use in its MicroRNA-Based Diagnostics |
7-Jan-2008 |
| Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma |
13-Dec-2007 |
| Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogen's MGB Probe Technology |
11-Dec-2007 |
| Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2007 Healthcare Conference |
7-Dec-2007 |
| Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008 |
3-Dec-2007 |
| Rosetta Genomics and NYU School of Medicine Expand Their microRNA-Based Collaboration to Include Cardiovascular Indications |
20-Nov-2007 |
| Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer |
14-Nov-2007 |
| Rosetta Genomics Reports Third Quarter 2007 Financial Results |
8-Nov-2007 |
| Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results |
1-Nov-2007 |
| Rosetta Genomics Completes Prevalidation Phase for First Diagnostic Product |
30-Oct-2007 |
| Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007 |
2-Oct-2007 |
| Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference |
14-Sep-2007 |
| Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference |
12-Sep-2007 |
| NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma |
7-Sep-2007 |
| Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007 |
27-Aug-2007 |
| Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008 |
10-Aug-2007 |
| Rosetta Genomics Reports Second Quarter 2007 Financial Results |
2-Aug-2007 |
| Rosetta Genomics and Ben Gurion University to Develop Microrna-Based Therapeutic Applications for Key Infectious Diseases Based on Viral Micrornas Discovered by Rosetta Genomics |
1-Aug-2007 |
| Rosetta Genomics is Issued Another Patent Relating to MicroRNAs |
31-Jul-2007 |
| Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results |
26-Jul-2007 |
| Rosetta Genomics Announces Expansion of its Research Facility |
17-Jul-2007 |
| Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression |
5-Jul-2007 |
| Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin Emerging Growth Opportunities Conference |
3-Jul-2007 |
| Rosetta Genomics In-Licenses Proprietary MicroRNAs for Therapeutic use From Rockefeller University |
13-Jun-2007 |
| Rosetta Genomics Signs Research Agreement With Columbia University Medical Center to Advance its Lead Cancer Diagnostics Program |
21-May-2007 |
| Rosetta Genomics Receives First Ever Patent Supporting MicroRNA-Based Diagnostics and Therapeutics |
15-May-2007 |
| Rosetta Genomics, a Leader in MicroRNA-based Diagnostics and Therapeutics Reports First Quarter 2007 Financial Results; Liver Cancer Therapeutics and Metastasis Classifier Diagnostic Projects Show Significant Progress |
8-May-2007 |
| Rosetta Genomics Ltd. Announces the Appointment of J. Michael French to President of its U.S Subsidiary, Rosetta Genomics, Inc. |
3-May-2007 |
| Rosetta Genomics to Announce First Quarter 2007 Financial Results and Host Conference Call on Tuesday, May 8, 2007 |
1-May-2007 |
| Rosetta Genomics Announces First Source for Clinical Validation of its Cancer of Unknown Primary (CUP) Diagnostic Test |
1-May-2007 |
| NYU Medical Center Partners With Rosetta Genomics to Develop a Line of Diagnostic Tools for Lung and Mesothelioma Cancers |
23-Apr-2007 |
| Rosetta Genomics Announces it has Presented Data on Advancements Made in the Company's Lead Assay Development Program for Cancer of Unknown Primary (CUP) |
20-Apr-2007 |
| Rosetta Genomics to Present Advancements in Its Cup Diagnostic Development Program |
12-Apr-2007 |
| Rosetta Genomics Announces the Development of a Proprietary MicroRNA Extraction Protocol From Blood Serum as Well as Advancements in Its Diagnostic and Therapeutic Development Programs At Cambridge Healthtech Institute's MicroRNA in Human Disease and Deve |
2-Apr-2007 |
| Rosetta Genomics to Present Advancements in Its Diagnostic and Therapeutic Development Programs At Cambridge Healthtech Institute's Microrna in Human Disease and Development Conference |
28-Mar-2007 |
| Rosetta Genomics Reports Fourth Quarter and 2006 Financial Results |
27-Mar-2007 |
| ROSETTA GENOMICS ANNOUNCES ALLOWANCE OF PATENTS COVERING HUMAN AND VIRAL MICRORNAS |
12-Mar-2007 |
| Rosetta Genomics Ltd. Announces Closing of Underwriters' Over-Allotment Option |
7-Mar-2007 |
| Rosetta Genomics Ltd. Announces Pricing of its Initial Public Offering |
27-Feb-2007 |
| ROSETTA GENOMICS AND MAX PLANCK SOCIETY ENTER MICRORNA LICENSING AGREEMENT |
26-Jul-2006 |
| ROSETTA GENOMICS AND ROCKEFELLER UNIVERSITY SIGN MICRORNA LICENSING AGREEMENT |
12-Jun-2006 |
| ROSETTA GENOMICS LTD. AND U.S. GENOMICS INC. ANNOUNCE COLLABORATION AGREEMENT TO DEVELOP A NON-INVASIVE microRNA-BASED EARLY DETECTION TEST FOR LUNG CANCER |
24-May-2006 |
| Isis Pharmaceuticals and Rosetta Genomics announce joint research collaboration to develop microRNA related therapies for the treatment of Liver Cancer |
22-Feb-2006 |
| Applied Biosystems acquired Ambion's Research Division along with Rosetta Genomics' licensing and commercialization agreement. |
27-Dec-2005 |
| AMBION AND ROSETTA GENOMICS ANNOUNCE LICENSING AND COMMERCIALIZATION DEAL TO ADVANCE MICRO-RNA RESEARCH |
12-Sep-2005 |
| Rosetta Genomics identifies hundreds of novel human microRNAs, as study published in Nature Genetics shows |
11-Jul-2005 |
 |
